Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.44 Billion USD | -1.09% |
| 2023 | 1.42 Billion USD | 1245.47% |
| 2022 | 105.55 Million USD | 32.25% |
| 2021 | 79.81 Million USD | 10.85% |
| 2020 | 72 Million USD | 24.49% |
| 2019 | 57.84 Million USD | 0.01% |
| 2018 | 57.83 Million USD | 2.09% |
| 2017 | 56.65 Million USD | 19.13% |
| 2016 | 47.55 Million USD | 15.37% |
| 2015 | 41.21 Million USD | 5.68% |
| 2014 | 39 Million USD | 25.96% |
| 2013 | 30.96 Million USD | -4.86% |
| 2012 | 32.54 Million USD | 6.07% |
| 2011 | 30.68 Million USD | 12.89% |
| 2010 | 27.18 Million USD | 101.38% |
| 2009 | 13.49 Million USD | -10.67% |
| 2008 | 15.1 Million USD | 13.27% |
| 2007 | 13.33 Million USD | -43.82% |
| 2006 | 23.74 Million USD | 162.37% |
| 2005 | 9.04 Million USD | -25.42% |
| 2004 | 12.13 Million USD | 82.89% |
| 2003 | 6.63 Million USD | 52.23% |
| 2002 | 4.35 Million USD | 18.26% |
| 2001 | 3.68 Million USD | -1.05% |
| 2000 | 3.72 Million USD | 61.91% |
| 1999 | 2.3 Million USD | 27.78% |
| 1998 | 1.8 Million USD | -14.29% |
| 1997 | 2.1 Million USD | -19.23% |
| 1996 | 2.6 Million USD | -3.7% |
| 1995 | 2.7 Million USD | 92.86% |
| 1994 | 1.4 Million USD | 16.67% |
| 1993 | 1.2 Million USD | 0.0% |
| 1992 | 1.2 Million USD | -14.29% |
| 1991 | 1.4 Million USD | -6.67% |
| 1990 | 1.5 Million USD | -83.52% |
| 1989 | 9.1 Million USD | -2.15% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.45 Billion USD | 2.82% |
| 2024 FY | 1.44 Billion USD | 1.39% |
| 2024 Q4 | 1.44 Billion USD | 0.26% |
| 2024 Q3 | 1.43 Billion USD | -1.27% |
| 2024 Q1 | 1.41 Billion USD | -0.37% |
| 2023 FY | 1.42 Billion USD | 1245.47% |
| 2023 Q3 | 1.38 Billion USD | -4.92% |
| 2023 Q2 | 1.45 Billion USD | 1454.09% |
| 2023 Q1 | 93.6 Million USD | -11.32% |
| 2023 Q4 | 1.42 Billion USD | 2.68% |
| 2022 Q3 | 104.35 Million USD | 3.11% |
| 2022 FY | 105.55 Million USD | 32.25% |
| 2022 Q4 | 105.55 Million USD | 1.15% |
| 2022 Q2 | 101.2 Million USD | 31.87% |
| 2022 Q1 | 76.74 Million USD | -3.85% |
| 2021 Q3 | 72.53 Million USD | 6.31% |
| 2021 Q2 | 68.23 Million USD | -2.59% |
| 2021 FY | 79.81 Million USD | 10.85% |
| 2021 Q1 | 70.04 Million USD | -2.72% |
| 2021 Q4 | 79.81 Million USD | 10.04% |
| 2020 FY | 72 Million USD | 24.49% |
| 2020 Q2 | 59.67 Million USD | -1.91% |
| 2020 Q3 | 61.63 Million USD | 3.28% |
| 2020 Q4 | 72 Million USD | 16.83% |
| 2020 Q1 | 60.83 Million USD | 5.18% |
| 2019 Q4 | 57.84 Million USD | 9.82% |
| 2019 Q2 | 58.41 Million USD | -1.49% |
| 2019 Q1 | 59.3 Million USD | 2.53% |
| 2019 FY | 57.84 Million USD | 0.01% |
| 2019 Q3 | 52.66 Million USD | -9.84% |
| 2018 Q3 | 53.66 Million USD | -11.13% |
| 2018 Q4 | 57.83 Million USD | 7.77% |
| 2018 FY | 57.83 Million USD | 2.09% |
| 2018 Q1 | 60.08 Million USD | 6.05% |
| 2018 Q2 | 60.38 Million USD | 0.5% |
| 2017 Q3 | 55.64 Million USD | 5.91% |
| 2017 Q1 | 51.39 Million USD | 8.08% |
| 2017 FY | 56.65 Million USD | 19.13% |
| 2017 Q2 | 52.53 Million USD | 2.22% |
| 2017 Q4 | 56.65 Million USD | 1.82% |
| 2016 Q2 | 47.88 Million USD | 12.14% |
| 2016 Q1 | 42.69 Million USD | 3.59% |
| 2016 FY | 47.55 Million USD | 15.37% |
| 2016 Q4 | 47.55 Million USD | 7.18% |
| 2016 Q3 | 44.36 Million USD | -7.34% |
| 2015 Q4 | 41.21 Million USD | -1.21% |
| 2015 Q2 | 39.12 Million USD | 0.85% |
| 2015 Q1 | 38.79 Million USD | -0.52% |
| 2015 Q3 | 41.72 Million USD | 6.64% |
| 2015 FY | 41.21 Million USD | 5.68% |
| 2014 Q3 | 39.22 Million USD | 3.49% |
| 2014 Q1 | 37.41 Million USD | 20.83% |
| 2014 FY | 39 Million USD | 25.96% |
| 2014 Q2 | 37.9 Million USD | 1.3% |
| 2014 Q4 | 39 Million USD | -0.57% |
| 2013 Q3 | 35.32 Million USD | 10.53% |
| 2013 Q4 | 30.96 Million USD | -12.35% |
| 2013 Q2 | 31.96 Million USD | 1.2% |
| 2013 Q1 | 31.58 Million USD | -2.96% |
| 2013 FY | 30.96 Million USD | -4.86% |
| 2012 Q3 | 30.36 Million USD | -2.66% |
| 2012 Q1 | 31.05 Million USD | 1.21% |
| 2012 Q4 | 32.54 Million USD | 7.19% |
| 2012 FY | 32.54 Million USD | 6.07% |
| 2012 Q2 | 31.19 Million USD | 0.44% |
| 2011 FY | 30.68 Million USD | 12.89% |
| 2011 Q4 | 30.68 Million USD | -0.37% |
| 2011 Q3 | 30.79 Million USD | -2.89% |
| 2011 Q2 | 31.71 Million USD | 6.23% |
| 2011 Q1 | 29.85 Million USD | 9.85% |
| 2010 FY | 27.18 Million USD | 101.38% |
| 2010 Q1 | 16.67 Million USD | 23.53% |
| 2010 Q2 | 19.28 Million USD | 15.69% |
| 2010 Q3 | 18.95 Million USD | -1.72% |
| 2010 Q4 | 27.18 Million USD | 43.37% |
| 2009 Q4 | 13.49 Million USD | -11.69% |
| 2009 FY | 13.49 Million USD | -10.67% |
| 2009 Q1 | 16.79 Million USD | 11.19% |
| 2009 Q3 | 15.28 Million USD | -4.99% |
| 2009 Q2 | 16.08 Million USD | -4.25% |
| 2008 Q4 | 15.1 Million USD | 4.77% |
| 2008 Q2 | 13.25 Million USD | 5.45% |
| 2008 Q1 | 12.56 Million USD | -5.77% |
| 2008 FY | 15.1 Million USD | 13.27% |
| 2008 Q3 | 14.42 Million USD | 8.8% |
| 2007 FY | 13.33 Million USD | -43.82% |
| 2007 Q1 | 11.27 Million USD | -52.51% |
| 2007 Q4 | 13.33 Million USD | 11.6% |
| 2007 Q2 | 12.71 Million USD | 12.76% |
| 2007 Q3 | 11.95 Million USD | -5.99% |
| 2006 Q3 | 24.05 Million USD | 151.72% |
| 2006 FY | 23.74 Million USD | 162.37% |
| 2006 Q4 | 23.74 Million USD | -1.3% |
| 2006 Q2 | 9.55 Million USD | -8.65% |
| 2006 Q1 | 10.46 Million USD | 15.6% |
| 2005 Q1 | 10.43 Million USD | -13.98% |
| 2005 Q2 | 11.42 Million USD | 9.48% |
| 2005 Q3 | 9.6 Million USD | -15.96% |
| 2005 Q4 | 9.04 Million USD | -5.76% |
| 2005 FY | 9.04 Million USD | -25.42% |
| 2004 Q4 | 12.13 Million USD | 2.89% |
| 2004 FY | 12.13 Million USD | 82.89% |
| 2004 Q3 | 11.79 Million USD | 26.19% |
| 2004 Q2 | 9.34 Million USD | 74.02% |
| 2004 Q1 | 5.37 Million USD | -19.05% |
| 2003 Q4 | 6.63 Million USD | 43.41% |
| 2003 FY | 6.63 Million USD | 52.23% |
| 2003 Q3 | 4.62 Million USD | -1.41% |
| 2003 Q2 | 4.69 Million USD | 6.68% |
| 2003 Q1 | 4.39 Million USD | 0.92% |
| 2002 Q1 | 3.4 Million USD | -7.63% |
| 2002 FY | 4.35 Million USD | 18.26% |
| 2002 Q2 | 3.36 Million USD | -1.26% |
| 2002 Q3 | 3.27 Million USD | -2.62% |
| 2002 Q4 | 4.35 Million USD | 33.15% |
| 2001 Q1 | 3.4 Million USD | -8.57% |
| 2001 Q4 | 3.68 Million USD | 22.87% |
| 2001 Q3 | 2.99 Million USD | 0.37% |
| 2001 Q2 | 2.98 Million USD | -12.25% |
| 2001 FY | 3.68 Million USD | -1.05% |
| 2000 Q1 | 1.9 Million USD | -17.39% |
| 2000 Q4 | 3.72 Million USD | 54.08% |
| 2000 FY | 3.72 Million USD | 61.91% |
| 2000 Q3 | 2.41 Million USD | 20.85% |
| 2000 Q2 | 2 Million USD | 5.26% |
| 1999 FY | 2.3 Million USD | 27.78% |
| 1999 Q4 | 2.3 Million USD | 35.29% |
| 1999 Q3 | 1.7 Million USD | -19.05% |
| 1999 Q2 | 2.1 Million USD | -4.55% |
| 1999 Q1 | 2.2 Million USD | 22.22% |
| 1998 Q1 | 2 Million USD | -4.76% |
| 1998 Q4 | 1.8 Million USD | -10.0% |
| 1998 Q3 | 2 Million USD | -4.76% |
| 1998 Q2 | 2.1 Million USD | 5.0% |
| 1998 FY | 1.8 Million USD | -14.29% |
| 1997 Q1 | 2.9 Million USD | 11.54% |
| 1997 Q4 | 2.1 Million USD | 5.0% |
| 1997 Q3 | 2 Million USD | 0.0% |
| 1997 Q2 | 2 Million USD | -31.03% |
| 1997 FY | 2.1 Million USD | -19.23% |
| 1996 Q3 | 2.8 Million USD | 0.0% |
| 1996 Q4 | 2.6 Million USD | -7.14% |
| 1996 Q2 | 2.8 Million USD | 7.69% |
| 1996 FY | 2.6 Million USD | -3.7% |
| 1996 Q1 | 2.6 Million USD | -3.7% |
| 1995 Q4 | 2.7 Million USD | 0.0% |
| 1995 FY | 2.7 Million USD | 92.86% |
| 1994 Q2 | 1.7 Million USD | 21.43% |
| 1994 FY | 1.4 Million USD | 16.67% |
| 1994 Q4 | 1.4 Million USD | 0.0% |
| 1994 Q1 | 1.4 Million USD | 16.67% |
| 1993 Q1 | 1.2 Million USD | 0.0% |
| 1993 FY | 1.2 Million USD | 0.0% |
| 1993 Q4 | 1.2 Million USD | 0.0% |
| 1992 Q4 | 1.2 Million USD | 0.0% |
| 1992 FY | 1.2 Million USD | -14.29% |
| 1991 FY | 1.4 Million USD | -6.67% |
| 1991 Q4 | 1.4 Million USD | 0.0% |
| 1990 Q4 | 1.5 Million USD | 0.0% |
| 1990 FY | 1.5 Million USD | -83.52% |
| 1989 FY | 9.1 Million USD | -2.15% |
| 1989 Q4 | 9.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bionano Genomics, Inc. | 118.24 Million USD | -1117.805% |
| Prenetics Global Limited | 44.01 Million USD | -3171.783% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -6543.682% |
| CareDx, Inc | 223.28 Million USD | -544.918% |
| Exact Sciences Corporation | 3.32 Billion USD | 56.705% |
| Exagen Inc. | 34.25 Million USD | -4104.432% |
| Inotiv, Inc. | 588.04 Million USD | -144.884% |
| Guardant Health, Inc. | 1.62 Billion USD | 11.533% |
| Biodesix, Inc. | 94.51 Million USD | -1423.571% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -82567.438% |
| Precipio, Inc. | 3.67 Million USD | -39116.176% |
| iSpecimen Inc. | 6.07 Million USD | -23592.066% |
| Natera, Inc. | 691.79 Million USD | -108.156% |
| Aspira Women's Health Inc. | 8.62 Million USD | -16591.99% |
| Standard BioTools Inc. | 159.86 Million USD | -800.771% |
| 23andMe Holding Co. | 206.64 Million USD | -596.849% |
| Castle Biosciences, Inc. | 86.54 Million USD | -1563.953% |
| Personalis, Inc. | 95.65 Million USD | -1405.382% |
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -3479.819% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -16302.676% |
| OpGen, Inc. | 13.44 Million USD | -10611.345% |
| T2 Biosystems, Inc. | 62.83 Million USD | -2191.818% |
| Myriad Genetics, Inc. | 312.9 Million USD | -360.217% |
| ICON Public Limited Company | 7.74 Billion USD | 81.417% |
| NeoGenomics, Inc. | 739.69 Million USD | -94.678% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -6543.682% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 18.89% |
| RadNet, Inc. | 2.07 Billion USD | 30.546% |
| MDxHealth SA | 121.92 Million USD | -1081.078% |
| Psychemedics Corporation | 6.59 Million USD | -21725.068% |
| Illumina, Inc. | 4.36 Billion USD | 67.017% |
| Check-Cap Ltd. | 1.33 Million USD | -108172.03% |
| Twist Bioscience Corporation | 152.97 Million USD | -841.367% |
| DarioHealth Corp. | 38.24 Million USD | -3665.245% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -929.886% |
| Sera Prognostics, Inc. | 25.28 Million USD | -5595.598% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -131389.64% |
| OPKO Health, Inc. | 622.47 Million USD | -131.336% |
| Medpace Holdings, Inc. | 1.09 Billion USD | -31.164% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -25634.496% |
| Prenetics Global Limited | 44.01 Million USD | -3171.783% |
| Mainz Biomed B.V. | 12.15 Million USD | -11742.446% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -42677.509% |
| Trinity Biotech plc | 83.38 Million USD | -1626.972% |
| Neuronetics, Inc. | 81.64 Million USD | -1663.842% |
| Sotera Health Company | 2.68 Billion USD | 46.402% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -42677.509% |